Author: Ahn, Dae-Gyun; Jeon, Il-Ji; Kim, Jung Dong; Song, Min-Sun; Han, Seung-Ryul; Lee, Seong-Wook; Jung, Hyungil; Oh, Jong-Won
                    Title: RNA aptamer-based sensitive detection of SARS coronavirus nucleocapsid protein.  Cord-id: acb81byu  Document date: 2009_1_1
                    ID: acb81byu
                    
                    Snippet: Severe acute respiratory syndrome coronavirus (SARS-CoV) is the etiological agent of a newly emerged disease SARS. The SARS-CoV nucleocapsid (N) protein is one of the most abundant structural proteins and serves as a diagnostic marker for accurate and sensitive detection of the virus. Using a SELEX (systematic evolution of ligand by exponential enrichment) procedure and recombinant N protein, we selected a high-affinity RNA aptamer capable of binding to N protein with a dissociation constant of 
                    
                    
                    
                     
                    
                    
                    
                    
                        
                            
                                Document: Severe acute respiratory syndrome coronavirus (SARS-CoV) is the etiological agent of a newly emerged disease SARS. The SARS-CoV nucleocapsid (N) protein is one of the most abundant structural proteins and serves as a diagnostic marker for accurate and sensitive detection of the virus. Using a SELEX (systematic evolution of ligand by exponential enrichment) procedure and recombinant N protein, we selected a high-affinity RNA aptamer capable of binding to N protein with a dissociation constant of 1.65 nM. Electrophoretic mobility shift assays and RNA competition experiments showed that the selected aptamer recognized selectively the C-terminal region of N protein with high specificity. Using a chemiluminescence immunosorbent assay and a nanoarray aptamer chip with the selected aptamer as an antigen-capturing agent, we could sensitively detect N protein at a concentration as low as 2 pg/ml. These aptamer-antibody hybrid immunoassays may be useful for rapid, sensitive detection of SARS-CoV N protein.
 
  Search related documents: 
                                
                                Co phrase  search for related documents, hyperlinks ordered by date